Actively Recruiting
A Prospective Observational Study to Explore Early Recovery in Lung Cancer Patients Undergoing Sublobar Resection Versus Lobectomy
Led by The First Affiliated Hospital of Guangzhou Medical University · Updated on 2025-12-17
300
Participants Needed
1
Research Sites
18 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are conducting a single-center, prospective observational study to understand how lung cancer patients recover after two types of surgery: sublobar resection and lobectomy. This study uses a multimodal digital device to analyze both subjective experiences and objective recovery measures. It aims to compare the early recovery outcomes of patients undergoing these surgical procedures. Patients are divided into two groups based on the surgery they receive through routine clinical decisions, not by random assignment. One group undergoes sublobar resection, which includes segmentectomy or wedge resection, while the other group undergoes standard lobectomy. Both groups will be observed prospectively to assess post-operative recovery and prognosis. Participants will provide electronic patient-reported outcomes starting one day before surgery until hospital discharge, for up to 15 days. Researchers will also collect data on hospital stay length, surgical time, and the number of lymph nodes removed during surgery. The study involves monitoring recovery through digital devices and tracking outcomes without altering routine care, with the total observation period lasting up to 15 days after surgery.
CONDITIONS
Brief Title
A Study to Explore the Early Subjective Evaluation and Objective Recovery in Lung Cancer Patients Undergoing Sublobar Resection Versus Lobectomy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients aged 18 years or older
- American Society of Anesthesiologists (ASA) grade III or below
- Scheduled for video-assisted thoracoscopic surgery (VATS) between March and December 2023
You will not qualify if you...
- Under 18 years of age
- Unable or unwilling to use wearable digital devices
- Do not have access to a smartphone
- Have incomplete digital device data during hospitalization
- Have lymph node or distant metastasis of cancer
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 15 days
Participants undergo surgical procedures including sublobar resection or lobectomy as part of their routine clinical care. Post-operative recovery is observed immediately after surgery during hospital stay.
Continuous monitoring from surgery until hospital discharge
Duration - Up to 15 days post-surgery
Participants are observed for early recovery outcomes after hospital discharge, including electronic patient-reported outcomes and recovery progress.
Follow-up assessments during hospital stay up to discharge, with possible remote data collection
Trial Site Locations
Total: 1 location
1
Department of Thoracic Surgery and Oncology, The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China
Actively Recruiting
Research Team
J
Jianxing He, M.D.
H
Hengrui Liang, M.D.
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here